Promising Therapy for radiation maculopathy
Intravitreal pharmacotherapy may moderate anatomic and visual effects of radiation-associated maculopathy
Sean Henahan
Published: Wednesday, January 11, 2017
Timothy Murray MD
Of most importance to the patients, at two months visual acuity had improved to 20/51, and at six months had improved to 20/32He described several cases where patients demonstrated dramatic improvement. One such case was a 76-year-old patient who had 20/400 BCVA at the beginning of the study. After receiving anti-VEGF treatment at six week intervals he improved to 20/30, with significant improvement also noted on OCT. Another patient, enrolled eight months post-brachytherapy, presented with both radiation maculopathy and optic neuropathy. After 66 weeks on the treat-and-extend protocol she also showed marked improvement on her OCT, with visual acuity improving from 20/400 to 20/30. “Ultimately, this interim data does suggest the potential for a large, multicentre randomised controlled clinical trial, and supports the recent shift within the ocular oncology community to the use of intravitreal pharmacotherapy in the management of radiation-related complications in uveal melanoma,” Dr Murray concluded. Timothy Murray: tmurray@murraymd.com
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular
Long-awaited cellular therapies for corneal endothelial disease enter the clinic.
Balancing Innovation and Safety
Ensuring access to advanced cell therapies amid regulatory overhaul.
With Eyes on Its Future, ESCRS Celebrates Its Past
Winter Meeting offers opportunities to experiment with new concepts and formats.
Best of ESCRS Winter Meeting 2024
Following the New Generation
EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.
Refocus on Multifocals
Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.
Common Myths in Presbyopia Correction
Patient education key to satisfaction with refractive IOLs.
Reversible Multifocality
Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.
Managing a Cataract Surgery Refractive Miss
Weighing the pros and cons of options for intraocular intervention.
Unleashing OCT’s Full Potential
Performance of newest tool for corneal evaluation meets or beats older standard technologies.